Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04452578 · ClinicalTrials.gov registry record · NA
Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients
A NA study of Heart Failure, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT04452578 is a NA study of Heart Failure that has completed, run by Loma Linda University. The registered enrollment target is 2 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04452578, a NA study of Heart Failure, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV negative heart recipients who are currently listed.
Conditions Studied
Interventions
- PROCEDURE Procedure: Heart Transplantation
Study Locations (1)
California
- Loma Linda University Transplant Institute - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-06-10 |
| Est. Completion | 2022-06-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04452578
The ClinicalTrials.gov registry entry for NCT04452578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Procedure: Heart Transplantation is the first listed.
NCT04452578 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04452578 about?
NCT04452578 is a clinical study titled "Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients". To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV negative heart recipients who are currently listed.
What is the current status of trial NCT04452578?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2020-06-10. Estimated completion is 2022-06-17.
What conditions does trial NCT04452578 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04452578?
The interventions under investigation include: Procedure: Heart Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT04452578?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04452578 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.